Back

The gender difference in risk factor and incidence rate of hospitalization for heart failure in Japanese atrial fibrillation patients: The Fushimi AF Registry

26 August 2023 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Heart failure and other structural heart diseases in atrial fibrillation Heart Failure in Atrial Fibrillation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Kosuke Doi

Kyoto Medical Centre, Kyoto (Japan)

6 More presentations in this session

Presentation thumbnail
The prognostic value of atrial fibrillation in patients with cardiac sarcoidosis
Doctor Y. Fujimoto (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Heart failure after left atrial appendage occlusion: insights from the LAAOS-III randomized trial
Assistant Professor P. Krisai (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Bleeding risk profile and heart failure hospitalizations in patients with atrial fibrillation according to FIB-4 index
Mr J. Parada Barcia (Vigo, ES)
Abstract Slides Video
Presentation thumbnail
Predictors of left ventricular reverse remodeling after catheter ablation for atrial fibrillation: sub analysis of a randomized controlled EARNEST-PVI trial
Doctor A. Sunaga (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Invasively diagnosed HFpEF in AF associated with functional remodelling of the left atrial appendage: implications for stroke risk
Doctor J. Ariyaratnam (Adelaide, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure and other structural heart diseases in atrial fibrillation

The Event

Event poster

ESC Congress 2023

26 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
The gender difference in cause of death in Japanese atrial fibrillation patients: The Fushimi AF Registry
thumbnail
Congress Presentation
Gender difference in patients hospitalized for acute heart failure in Korea
thumbnail
Congress Presentation
Gender differences in atrial cardiomyopathy: insights from patients with atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources